Julieta Grasselli
L'hospitalet De Llobregat, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden.
Journal: Journal for immunotherapy of cancer
Published: June 14, 2024
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 04, 2017
Current and advancing treatments for metastatic colorectal cancer.
Journal: Expert opinion on biological therapy
Published: November 10, 2015
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.
Journal: Molecular cancer therapeutics
Published: October 06, 2015
Intrinsic cancer subtypes--next steps into personalized medicine.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 09, 2014
Tenth anniversary of bevacizumab in colorectal cancer: has it fulfilled its promise?
Journal: Future oncology (London, England)
Published: February 05, 2014
TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer.
Journal: Clinical & experimental metastasis
Published: February 28, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026